Barbara Wiggins to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Barbara Wiggins has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
2.447
-
Statin-associated muscle symptoms-A review: Individualizing the approach to optimize care. Pharmacotherapy. 2022 05; 42(5):428-438.
Score: 0.727
-
Recommendations for Managing Drug-Drug Interactions with Statins and HIV Medications. Am J Cardiovasc Drugs. 2017 Oct; 17(5):375-389.
Score: 0.531
-
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2016 11 22; 134(21):e468-e495.
Score: 0.497
-
Gemfibrozil in Combination with Statins-Is It Really Contraindicated? Curr Atheroscler Rep. 2016 Apr; 18(4):18.
Score: 0.479
-
Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update. J Pharm Pract. 2020 Dec; 33(6):882-894.
Score: 0.151
-
Role of P-glycoprotein in statin drug interactions. Pharmacotherapy. 2006 Nov; 26(11):1601-7.
Score: 0.062